The SAM occupational health market is expected to grow from US$ 272.67 million in 2021 to US$ 322.44 million by 2028; it is estimated to register a CAGR of 2.4% from 2021 to 2028.
According to World Health Organization (WHO), various factors in the working environment affect mental health. As per the Centre for Workplace Mental Health data, excessive workplace stress causes a staggering 120,000 deaths and results in ~$190 billion in health care costs each year. The healthcare cost mentioned above represents 5-8% of national health care spending, derived primarily from high demands at work ($48 billion), lack of insurance ($40 billion), and work-family conflict ($24 billion). To reduce the incidence of health-related issues, many companies are adopting wellness programs for their employees to be productive. The adoption of mental health and wellness programs increased after the emergence of the COVID-19 pandemic. Thus, companies are adopting wellness programs to compensate for the sizable emotional, psychological, and physical strain of the COVID-19 pandemic. Hence, the pandemic has led to lucrative opportunities for the key players operating in the occupational health market to provide mental health and wellness programs, which is expected to fuel the market growth in the coming years across the region.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM occupational health market at a notable CAGR during the forecast period.
The SAM occupational health market is bifurcated into type and country. Based on type, the market is segmented into work-induced stress, asbestosis, hearing loss due to noise, disorders caused due to chemicals and vibrations, and others. In 2021, the hearing loss due to noise segment dominated the market, and the work-induced stress segment is expected to register the highest CAGR during the forecast period. Based on country, the SAM occupational health market is segmented into Brazil, Argentina, and the Rest of SAM.
Amgen Inc.; Johnson and Johnson Services, Inc; Novartis AG; and Occucare International are among the leading companies operating in the SAM occupational health market.